155 related articles for article (PubMed ID: 7525331)
1. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism.
Brouillet E; Hyman BT; Jenkins BG; Henshaw DR; Schulz JB; Sodhi P; Rosen BR; Beal MF
Exp Neurol; 1994 Oct; 129(2):175-82. PubMed ID: 7525331
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.
Beal MF; Brouillet E; Jenkins BG; Ferrante RJ; Kowall NW; Miller JM; Storey E; Srivastava R; Rosen BR; Hyman BT
J Neurosci; 1993 Oct; 13(10):4181-92. PubMed ID: 7692009
[TBL] [Abstract][Full Text] [Related]
3. 3-Acetylpyridine produces age-dependent excitotoxic lesions in rat striatum.
Schulz JB; Henshaw DR; Jenkins BG; Ferrante RJ; Kowall NW; Rosen BR; Beal MF
J Cereb Blood Flow Metab; 1994 Nov; 14(6):1024-9. PubMed ID: 7929644
[TBL] [Abstract][Full Text] [Related]
4. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB
Synapse; 1989; 3(1):38-47. PubMed ID: 2563916
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate.
Beal MF; Brouillet E; Jenkins B; Henshaw R; Rosen B; Hyman BT
J Neurochem; 1993 Sep; 61(3):1147-50. PubMed ID: 7689641
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of suicide transport lesions of the striatonigral or striatopallidal pathways on subsets of striatal neurons.
Roberts RC; Harrison MB; Francis SM; Wiley RG
Exp Neurol; 1993 Dec; 124(2):242-52. PubMed ID: 7507060
[TBL] [Abstract][Full Text] [Related]
7. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease.
Beal MF; Ferrante RJ; Swartz KJ; Kowall NW
J Neurosci; 1991 Jun; 11(6):1649-59. PubMed ID: 1710657
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Chen Q; Reiner A
Exp Neurol; 1997 Aug; 146(2):444-57. PubMed ID: 9270055
[TBL] [Abstract][Full Text] [Related]
9. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum.
Uemura Y; Kowall NW; Beal MF
Ann Neurol; 1990 Jun; 27(6):620-5. PubMed ID: 1972876
[TBL] [Abstract][Full Text] [Related]
10. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism.
Brouillet EP; Shinobu L; McGarvey U; Hochberg F; Beal MF
Exp Neurol; 1993 Mar; 120(1):89-94. PubMed ID: 8477830
[TBL] [Abstract][Full Text] [Related]
11. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome.
Roberts RC; Ahn A; Swartz KJ; Beal MF; DiFiglia M
Exp Neurol; 1993 Dec; 124(2):274-82. PubMed ID: 8287926
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of the generation of different striatal neuronal subtypes in the adult brain following excitotoxic injury.
Collin T; Arvidsson A; Kokaia Z; Lindvall O
Exp Neurol; 2005 Sep; 195(1):71-80. PubMed ID: 15936016
[TBL] [Abstract][Full Text] [Related]
13. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.
Bazzett TJ; Becker JB; Kaatz KW; Albin RL
Exp Neurol; 1993 Apr; 120(2):177-85. PubMed ID: 8387931
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
[TBL] [Abstract][Full Text] [Related]
15. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats.
Figueredo-Cardenas G; Anderson KD; Chen Q; Veenman CL; Reiner A
Exp Neurol; 1994 Sep; 129(1):37-56. PubMed ID: 7925841
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats.
Kim JH; Kim S; Yoon IS; Lee JH; Jang BJ; Jeong SM; Lee JH; Lee BH; Han JS; Oh S; Kim HC; Park TK; Rhim H; Nah SY
Neuropharmacology; 2005 Apr; 48(5):743-56. PubMed ID: 15814108
[TBL] [Abstract][Full Text] [Related]
18. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
[TBL] [Abstract][Full Text] [Related]
19. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
20. In vivo effects of inorganic mercury (HgCl(2)) on striatal dopaminergic system.
Faro LR; do Nascimento JL; Alfonso M; Durán R
Ecotoxicol Environ Saf; 2001 Mar; 48(3):263-7. PubMed ID: 11222035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
